Skip to main content
. 2022 Oct 21;8(1):101109. doi: 10.1016/j.adro.2022.101109

Table 1.

Male patient characteristics

Male patient number Age (y) Tumor stage Tumor location
1 60 T3 N2 Lower
2 73 T3 N1 Upper
3 68 T3 N2 Mid
4 40 T3 N0 Upper
5 67 T3 N3 Lower
6 74 T3 N2 Mid
7 51 T3 N2 Lower
8 55 T2 N1 Upper
9 58 T3 N2 Upper
10 58 T3 N2 Mid
11 69 T3 N2 Mid
12 75 T3 N2 Upper
13 64 T3 N3 Lower
14 46 T3 N2 Mid
15 61 T3 N3 Mid
16 74 T3 N1 Lower
17 66 T2 N2 Lower
18 70 T3 N1 Lower
19 72 T2 N1 Lower